Mohammad Ali Saremi

Mohammad Ali Saremi has been working in the field of genetics since 2002. Mohammad Ali began their career as a Researcher at Université Nice Sophia Antipolis, followed by a role as Forensic Genetics at the National Institute of Standards and Technology in 2009. In 2010, they became the Owner & Founder of several companies such as GPMG, AramisGen, RayaGen, TahaGen, SinaGen, and more. In 2013, they took on the role of Owner, Founder and Chairman of the Board at AmitisGen Med TECH Group. In 2014, they became the Project Manager for the Iran (Middle East) at OncoDNA. Most recently, in 2017, they were appointed as President at the Personalized Medicine Research Center.

Mohammad Ali Saremi obtained a Research Doctorate from Université Nice Sophia Antipolis in 2010, following a Master's degree in Molecular Genetics from Tehran University of Medical Sciences in 2005. Mohammad Ali also holds a Certification for Graduation Degree.